Variables
Controls (n = 62)
Total PCOS (n = 40)
NIR-PCOS (n = 22)
IR-PCOS (n = 18)
TSH (μIU/ml)
2.29 ± 0.76
b*
2.7 ± 1.23
2.3 ± 1.11
b*
3.15 ± 1.34
FT3 (Pg/ml)
2.8 ± 0.80
2.72 ± 0.69
2.59 ± 0.67
2.9 ± 0.54
FT4 (ng/dl)
1.4 ± 0.45
1.35 ± 0.36
1.46 ± 0.32
1.23 ± 0.43
Thyroid volume (ml)
12.87 ± 4.90
b*
14.91 ± 5.68
13.01 ± 4.51
b*
16.96 ± 6.8
Thyroid nodule n (%)
•Palpable n (%)
•Non-palpable n (%)
8/62 (12.9%)
b*
3/8 (37.5%)
5/8 (62.5%)
10/40 (25%)
3/10 (30%)
7/10 (70%)
3/22 (13.6%)
1/3 (33.3%)
2/3 (66.6%)
7/18 (38.8%)
2/7 (28.6%)
5/7 (71.4%)
Data are expressed as mean ± standard deviation or percentages
a: versus total PCOS, b: versus IR-PCOS, c: versus NIR-PCOS, *P < 0.05, **P < 0.01
Table 2:
Thyroid function and volume in PCOS women and controls.
